Back to Search Start Over

Neuronal cell-based high-throughput screen for enhancers of mitochondrial function reveals luteolin as a modulator of mitochondria-endoplasmic reticulum coupling.

Authors :
Naia L
Pinho CM
Dentoni G
Liu J
Leal NS
Ferreira DMS
Schreiner B
Filadi R
Fão L
Connolly NMC
Forsell P
Nordvall G
Shimozawa M
Greotti E
Basso E
Theurey P
Gioran A
Joselin A
Arsenian-Henriksson M
Nilsson P
Rego AC
Ruas JL
Park D
Bano D
Pizzo P
Prehn JHM
Ankarcrona M
Source :
BMC biology [BMC Biol] 2021 Mar 24; Vol. 19 (1), pp. 57. Date of Electronic Publication: 2021 Mar 24.
Publication Year :
2021

Abstract

Background: Mitochondrial dysfunction is a common feature of aging, neurodegeneration, and metabolic diseases. Hence, mitotherapeutics may be valuable disease modifiers for a large number of conditions. In this study, we have set up a large-scale screening platform for mitochondrial-based modulators with promising therapeutic potential.<br />Results: Using differentiated human neuroblastoma cells, we screened 1200 FDA-approved compounds and identified 61 molecules that significantly increased cellular ATP without any cytotoxic effect. Following dose response curve-dependent selection, we identified the flavonoid luteolin as a primary hit. Further validation in neuronal models indicated that luteolin increased mitochondrial respiration in primary neurons, despite not affecting mitochondrial mass, structure, or mitochondria-derived reactive oxygen species. However, we found that luteolin increased contacts between mitochondria and endoplasmic reticulum (ER), contributing to increased mitochondrial calcium (Ca <superscript>2+</superscript> ) and Ca <superscript>2+</superscript> -dependent pyruvate dehydrogenase activity. This signaling pathway likely contributed to the observed effect of luteolin on enhanced mitochondrial complexes I and II activities. Importantly, we observed that increased mitochondrial functions were dependent on the activity of ER Ca <superscript>2+</superscript> -releasing channels inositol 1,4,5-trisphosphate receptors (IP <subscript>3</subscript> Rs) both in neurons and in isolated synaptosomes. Additionally, luteolin treatment improved mitochondrial and locomotory activities in primary neurons and Caenorhabditis elegans expressing an expanded polyglutamine tract of the huntingtin protein.<br />Conclusion: We provide a new screening platform for drug discovery validated in vitro and ex vivo. In addition, we describe a novel mechanism through which luteolin modulates mitochondrial activity in neuronal models with potential therapeutic validity for treatment of a variety of human diseases.

Details

Language :
English
ISSN :
1741-7007
Volume :
19
Issue :
1
Database :
MEDLINE
Journal :
BMC biology
Publication Type :
Academic Journal
Accession number :
33761951
Full Text :
https://doi.org/10.1186/s12915-021-00979-5